Smiths Group (SMGZY) Stock Rating Upgraded by Morgan Stanley
Smiths Group (OTCMKTS:SMGZY) was upgraded by equities researchers at Morgan Stanley from an “underweight” rating to an “equal weight” rating in a research note issued on Wednesday.
Smiths Group (SMGZY) remained flat at $$19.94 during trading hours on Wednesday. The company’s stock had a trading volume of 10,747 shares, compared to its average volume of 26,997. The company has a debt-to-equity ratio of 0.76, a quick ratio of 1.82 and a current ratio of 2.34. Smiths Group has a 1 year low of $17.09 and a 1 year high of $22.33.
ILLEGAL ACTIVITY NOTICE: This report was first posted by American Banking News and is the property of of American Banking News. If you are accessing this report on another publication, it was stolen and reposted in violation of U.S. & international copyright laws. The correct version of this report can be read at https://www.americanbankingnews.com/2017/12/13/smiths-group-smgzy-upgraded-by-morgan-stanley-to-equal.html.
About Smiths Group
Smiths Group plc is a technology company. The Company operates in five divisions: John Crane, Smiths Medical, Smiths Detection, Smiths Interconnect and Flex-Tek. The John Crane division offers mechanical seals, seal support systems, engineered bearings and power transmission couplings, among others. The Smiths Medical division offers infusion systems, vascular access (including safety needles), patient airway and temperature management equipment, and specialty devices in areas of in vitro fertilization, diagnostics and emergency patient transport.
Receive News & Ratings for Smiths Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smiths Group and related companies with MarketBeat.com's FREE daily email newsletter.